Molecular Diagnostics Laboratory
Laboratory Overview
The Molecular Diagnostics Laboratory is operated as a reference laboratory by the Department of Pathology at UT Health San Antonio. The laboratory is involved in teaching medical students, residents, and fellows, and also provides support services for faculty and staff of UT Health, as well as services to outside entities on a predominantly fee-for-service basis.
The laboratory develops and performs molecular diagnostic tests for nucleic acid targets found in a variety of settings in medicine. The laboratory performs hematopathology, solid tumor and molecular microbiological testing as well as a selection of genetic and infectious disease tests.
The Molecular Diagnostics Laboratory is fully accredited by and participates in the College of American Pathologists (CAP) inspection and accreditation programs.
Through the deemed status granted to the CAP, the laboratory is also accredited by the Health Care Financing Administration through the Clinical Laboratory Improvement Act (CLIA) for the performance of high complexity testing. Current certificates of accreditation may be viewed here: CAP, CLIA.*
SARS-CoV-2 (COVID-19) Testing
If you are an employee, student, resident, or family member, login below to schedule your COVID19 test:
Schedule your test here
For existing patients, use your MyChart account to schedule a test.
For new patients, create a MyChart account and schedule a test.
Test Menu
Tests Currently Performed by the Molecular Diagnostics Laboratory
Hematopathology
BCL2::IGH translocation major breakpoint by real-time PCR
BCR::ABL1 p210 quantitation by real-time PCR and report on IS
BCR::ABL1 p190 quantitation by real-time PCR
PML::RARA translocation t(15;17) by real-time PCR
JAK2 (p.V617F) quantitative variant analysis by real-time PCR
IGH clonality detection by PCR and capillary electrophoresis
IGK clonality detection by PCR and capillary electrophoresis
TCRG clonality detection by PCR and capillary electrophoresis
TCRB clonality detection by PCR and capillary electrophoresis
Solid Tumor
UT Health San Antonio Solid Tumor OncoPanel by NGS
Inherited disease
F5 Leiden (p.R506Q) variant analysis by real-time PCR
Prothrombin (F2) c*.97G>A or 20210G>A variant analysis by real-time PCR
Hemochromatosis (HFE) 2 variants analysis by real-time PCR
Infectious disease
Chlamydia trachomatis by transcription-mediated amplification (TMA)
Neisseria gonorrhoeae testing by transcription-mediated amplification (TMA)
COVID-19 (SARS-CoV-2) Nucleic Acid Test, Nasopharyngeal (TMA)
COVID-19 (SARS-CoV-2)/FLU/RSV Nucleic Acid Test, Nasopharyngeal
Gastrointestinal Pathogen Panel molecular assay with 22 pathogens
Respiratory Pathogen Panel (RP2.1) molecular assay with 22 pathogens, including SARS-CoV-2
Fungal molecular identification (order through the Fungal Testing Laboratory)